D&D Pharmatech Inc. (KOSDAQ: 347850)
South Korea
· Delayed Price · Currency is KRW
33,700
+100 (0.30%)
Sep 11, 2024, 9:00 AM KST
D&D Pharmatech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Debt / Equity Ratio | 0.10 | 0.15 | 1.47 | 0.32 | 0.03 | 0.02 | |
| Debt / FCF Ratio | -0.63 | -0.89 | -0.51 | -0.81 | -0.11 | -0.11 | |
| Asset Turnover | - | 0.22 | 0.00 | 0.01 | - | - | |
| Quick Ratio | 4.86 | 2.28 | 0.47 | 1.14 | 6.63 | 1.14 | |
| Current Ratio | 5.38 | 2.61 | 0.61 | 1.22 | 7.28 | 1.18 | |
| Return on Equity (ROE) | - | 9.29% | -174.72% | -43.71% | -38.23% | -8.26% | |
| Return on Assets (ROA) | - | -9.75% | -24.89% | -19.70% | -16.52% | -12.50% | |
| Return on Capital (ROIC) | - | -15.45% | -37.70% | -25.64% | -25.07% | -24.62% | |
| Buyback Yield / Dilution | -18.02% | -16.38% | 2.05% | -12.66% | -118.38% | -33.79% | |
| Total Shareholder Return | -18.02% | -16.38% | 2.05% | -12.66% | -118.38% | -33.79% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.